News
Regardless of treatment modality, effective control of hypercortisolism in patients with bilateral adrenal tumors is key to achieving favorable cardiovascular outcomes, suggests a data analysis of the ENSAT trial.
Cushing’s Hub is proud to support Rare Disease Day 2026—an annual rare moment that unites patients, families, clinicians, and advocates to bring rare diseases into the spotlight.
People with cyclic Cushing’s syndrome have a high risk for spontaneous adrenal insufficiency, delayed diagnosis, and inappropriate surgeries, suggests an observational study in The Lancet Diabetes and Endocrinology.
The Editorial Board is delighted to congratulate Dr Stefano Testa of the Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy, on being selected as this year’s winner of the prestigious Cushing’s Hub Competition.
Measuring biochemical severity scores before adrenalectomy in people with mild autonomous cortisol secretion could help to identify those likely to develop adrenal insufficiency, suggest researchers.
Surgery to remove all or part of an adrenal gland can help reduce hypertension in people with unilateral incidentalomas and mild autonomous cortisol secretion, suggest findings from the CHIRACIC study.



